<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="deo2414" xml:lang="en" article-type="case-study"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">DEN Open</journal-id><journal-id journal-id-type="iso-abbrev">DEN Open</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2692-4609</journal-id><journal-id journal-id-type="publisher-id">DEO2</journal-id><journal-title-group><journal-title>DEN Open</journal-title></journal-title-group><issn pub-type="epub">2692-4609</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39077549</article-id><article-id pub-id-type="pmc">PMC11284119</article-id>
<article-id pub-id-type="doi">10.1002/deo2.414</article-id><article-id pub-id-type="publisher-id">DEO2414</article-id><article-categories><subj-group subj-group-type="overline"><subject>Case Report</subject></subj-group><subj-group subj-group-type="heading"><subject>Case Report</subject></subj-group></article-categories><title-group><article-title>Unique endoscopic features of primary biliary diffuse large B&#x02010;cell lymphoma: A case report with literature review (with video)</article-title><alt-title alt-title-type="left-running-head">NAKAMURA <sc>et al</sc>.</alt-title></title-group><contrib-group><contrib id="deo2414-cr-0001" contrib-type="author"><name><surname>Nakamura</surname><given-names>Tomoya</given-names></name><xref rid="deo2414-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2414-cr-0002" contrib-type="author" corresp="yes"><name><surname>Masaki</surname><given-names>Yoshiharu</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8765-6074</contrib-id><xref rid="deo2414-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>yoshiharu.masaki@gmail.com</email></address></contrib><contrib id="deo2414-cr-0003" contrib-type="author"><name><surname>Kameyama</surname><given-names>Naohiro</given-names></name><xref rid="deo2414-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2414-cr-0004" contrib-type="author"><name><surname>Kawakami</surname><given-names>Yujiro</given-names></name><xref rid="deo2414-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2414-cr-0005" contrib-type="author"><name><surname>Ishigami</surname><given-names>Keisuke</given-names></name><xref rid="deo2414-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2414-cr-0006" contrib-type="author"><name><surname>Takada</surname><given-names>Yumemi</given-names></name><xref rid="deo2414-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="deo2414-cr-0007" contrib-type="author"><name><surname>Satoh</surname><given-names>Shuji</given-names></name><xref rid="deo2414-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="deo2414-cr-0008" contrib-type="author"><name><surname>Sugawara</surname><given-names>Taro</given-names></name><xref rid="deo2414-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="deo2414-cr-0009" contrib-type="author"><name><surname>Sugita</surname><given-names>Shintaro</given-names></name><xref rid="deo2414-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="deo2414-cr-0010" contrib-type="author"><name><surname>Nakase</surname><given-names>Hiroshi</given-names></name><xref rid="deo2414-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="deo2414-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Gastroenterology and Hepatology</named-content>
<institution>Sapporo Medical University School of Medicine</institution>
<city>Hokkaido</city>
<country country="JP">Japan</country>
</aff><aff id="deo2414-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Gastroenterology and Hepatology</named-content>
<institution>Obihiro Kyokai Hospital</institution>
<city>Hokkaido</city>
<country country="JP">Japan</country>
</aff><aff id="deo2414-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Department of Surgical Pathology</named-content>
<institution>Sapporo Medical University School of Medicine</institution>
<city>Hokkaido</city>
<country country="JP">Japan</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence</bold>
<break/>Yoshiharu Masaki, Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine, S&#x02010;1, W&#x02010;16, Chuo&#x02010;ku, Sapporo, Hokkaido 060&#x02013;8543, Japan.<break/> Email: <email>yoshiharu.masaki@gmail.com</email>
<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>28</day><month>7</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>4</month><year>2025</year></pub-date><volume>5</volume><issue seq="101">1</issue><issue-id pub-id-type="doi">10.1002/deo2.v5.1</issue-id><elocation-id>e414</elocation-id><history>
<date date-type="rev-recd"><day>20</day><month>6</month><year>2024</year></date>
<date date-type="received"><day>26</day><month>3</month><year>2024</year></date>
<date date-type="accepted"><day>14</day><month>7</month><year>2024</year></date>
</history><permissions><!--&#x000a9; 2025 John Wiley & Sons Ltd.--><copyright-statement content-type="article-copyright">&#x000a9; 2024 The Author(s). <italic toggle="yes">DEN Open</italic> published by John Wiley &#x00026; Sons Australia, Ltd on behalf of Japan Gastroenterological Endoscopy Society.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:DEO2-5-e414.pdf"/><abstract><title>Abstract</title><p>A 67&#x02010;year&#x02010;old man visited our hospital complaining of dark&#x02010;colored urine and upper abdominal pain. Magnetic resonance cholangiopancreatography showed stricture of the distal bile duct, and contrast&#x02010;enhanced computed tomography showed irregular thickening of the distal bile duct wall. However, no enlarged lymph nodes, pancreatic tumors, or other neoplastic lesions were apparent around the bile duct. Endoscopic ultrasonography and intraductal ultrasonography showed irregular thickening of the inner hypoechoic layer without the disappearance of the innermost thin hyperechoic layer. On the basis of these findings, we considered that the bile duct lesion was of non&#x02010;epithelial origin. Thus, we repeatedly performed bile duct biopsies from the same site under fluoroscopy to obtain a sample of the submucosal tissue. The pathological diagnosis was diffuse large B&#x02010;cell lymphoma, and the patient received systemic chemotherapy (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone). After six courses of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone, positron emission tomography&#x02010;computed tomography showed the disappearance of 18&#x02010;fluorodeoxyglucose uptake in the bile duct and endoscopic retrograde cholangiography showed improvement of the bile duct stricture. Endoscopic findings and repeated biopsies were useful in making the diagnosis of primary biliary diffuse large B&#x02010;cell lymphoma.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="deo2414-kwd-0001">biliary malignant lymphoma</kwd><kwd id="deo2414-kwd-0002">diffuse large B&#x02010;cell lymphoma</kwd><kwd id="deo2414-kwd-0003">malignant biliary obstruction</kwd><kwd id="deo2414-kwd-0004">endoscopic ultrasonography</kwd><kwd id="deo2414-kwd-0005">intraductal ultrasonography</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>None</funding-source></award-group></funding-group><counts><fig-count count="3"/><table-count count="1"/><page-count count="5"/><word-count count="2313"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>April 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.4 mode:remove_FC converted:27.02.2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="deo2414-sec-0010"><title>INTRODUCTION</title><p>Primary biliary malignant lymphoma (PBML) that causes biliary obstruction is extremely rare.<xref rid="deo2414-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref> The endoscopic findings of PBML are still unclear; therefore, preoperative diagnosis is difficult, and most patients are diagnosed using postoperative pathology.<xref rid="deo2414-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> However, malignant lymphoma can be cured with non&#x02010;surgical treatments, such as chemotherapy, radiotherapy, and chemoradiotherapy. Thus, it is important to diagnose PBML using non&#x02010;surgical methods, such as endoscopic biopsy.</p><p>Herein, we describe a patient with primary biliary diffuse large B&#x02010;cell lymphoma (DLBCL), who showed unique findings on endoscopic ultrasonography (EUS) and intraductal ultrasonography (IDUS).</p><sec id="deo2414-sec-0020"><title>Case report</title><p>A 67&#x02010;year&#x02010;old man visited our hospital complaining of dark&#x02010;colored urine and upper abdominal pain. He had a history of asthma and hypertension, but no history of abdominal surgery. The physical examination did not reveal conjunctival icterus, superficial lymphadenopathy, abdominal tenderness, or hepatosplenomegaly. Laboratory tests showed normal levels of total bilirubin (0.9 mg/dL; reference range, 0.4&#x02013;1.5 mg/dL) and lactate dehydrogenase (219 U/L; reference range, 124&#x02013;222 U/L) but elevated levels of transaminases (aspartate aminotransferase level, 43 U/L [reference range, 13&#x02013;30 U/L]; alanine aminotransferase level, 92 U/L [reference range, 10&#x02013;42 U/L]), alkaline phosphatase level (191 U/L; reference range, 38&#x02013;113 U/L) and gamma&#x02010;glutamyl transferase (764 U/L; reference range, 13&#x02013;64 U/L). Serum levels of carcinoembryonic antigen, carbohydrate antigen 19&#x02010;9, and soluble interleukin&#x02010;2 receptor were negative. Additionally, the serum immunoglobulin&#x02010;G4 level was normal (47.6 mg/dL; reference range, 11&#x02013;121 mg/dL). Magnetic resonance cholangiopancreatography showed a stricture in the distal bile duct with dilatation of the proximal bile duct. Contrast&#x02010;enhanced computed tomography (CT) revealed irregular thickening of the distal bile duct wall; however, no enlarged lymph nodes, pancreatic tumors, or other neoplastic lesions around the bile duct were apparent (Figure&#x000a0;<xref rid="deo2414-fig-0001" ref-type="fig">1a&#x02013;c</xref>, <xref rid="deo2414-supitem-0001" ref-type="supplementary-material">S1</xref>). Positron emission tomography&#x02010;CT showed abnormal 18&#x02010;fluorodeoxyglucose uptake at the site of the bile duct stricture, with a maximum standardized uptake value of 32.29 (Figure&#x000a0;<xref rid="deo2414-fig-0001" ref-type="fig">1d</xref>). EUS revealed irregular thickening of the inner hypoechoic layer of the bile duct without the disappearance of the innermost thin hyperechoic layer (Figure&#x000a0;<xref rid="deo2414-fig-0002" ref-type="fig">2a,b</xref>). Endoscopic retrograde cholangiography (ERC) showed a distal bile duct stricture with a dilated proximal bile duct (Figure&#x000a0;<xref rid="deo2414-fig-0002" ref-type="fig">2c</xref>), and subsequently, IDUS revealed irregular thickening of the inner hypoechoic layer without disappearance of the innermost thin hyperechoic layer, as shown by EUS (Figure&#x000a0;<xref rid="deo2414-fig-0003" ref-type="fig">3d</xref>). On the basis of the EUS and IDUS findings, we considered that the bile duct lesion was of non&#x02010;epithelial origin and repeatedly performed 10 times bile duct biopsies, using the biopsy forceps (Radial Jaw <sup>TM</sup>; Boston Scientific), aiming the same level under fluoroscopy to obtain a sample of the submucosal tissue (video <xref rid="deo2414-supitem-0003" ref-type="supplementary-material">S3</xref>). Pathological findings (Figure&#x000a0;<xref rid="deo2414-fig-0003" ref-type="fig">3a&#x02013;d</xref>) revealed a diffuse proliferation of large atypical lymphocytes with irregular nuclear shapes. Immunohistochemical staining showed that the lymphocytes were positive for B&#x02010;cell markers (CD20 and CD79a) and negative for T&#x02010;cell markers (CD3 and CD5). Therefore, we diagnosed the patient with DLBCL (Lugano classification stage I, and the revised International Prognostic Index score of 1).</p><fig position="float" fig-type="FIGURE" id="deo2414-fig-0001"><label>FIGURE 1</label><caption><p>Radiological findings of the bile duct lesion: (a, b) Axial and coronal contrast&#x02010;enhanced computed tomography images showing irregular thickening of the distal bile duct wall. (c) Magnetic resonance cholangiopancreatography reveals stricture of the distal bile duct with dilatation of the proximal bile duct. (d) Positron emission&#x02010;computed tomography reveals abnormal 18&#x02010;fluorodeoxyglucose uptake at the site of the bile duct stricture. The maximum standardized uptake value is 32.29.</p></caption><graphic xlink:href="DEO2-5-e414-g002" position="anchor" id="jats-graphic-1"/></fig><fig position="float" fig-type="FIGURE" id="deo2414-fig-0002"><label>FIGURE 2</label><caption><p>Findings of endoscopic ultrasonography (EUS), endoscopic retrograde cholangiography (ERC), and intraductal ultrasonography (IDUS): (a, b) EUS reveals irregular thickening of the inner hypoechoic layer without the disappearance of the innermost thin hyperechoic layer (arrow). A hyperechoic mass indicating a bile duct stone is also detected (*). (c) ERC shows the distal bile duct stricture with a dilated proximal bile duct. (d) IDUS of the bile duct stricture site shows irregular thickening of the inner hypoechoic layer without the disappearance of the innermost thin hyperechoic layer, as seen on endoscopic ultrasonography.</p></caption><graphic xlink:href="DEO2-5-e414-g001" position="anchor" id="jats-graphic-3"/></fig><fig position="float" fig-type="FIGURE" id="deo2414-fig-0003"><label>FIGURE 3</label><caption><p>Pathological findings of bile duct biopsy specimens: (a, b) Hematoxylin and eosin staining shows diffuse proliferation of large atypical lymphocytes with irregular nuclear shapes (a: &#x000d7;100, b: &#x000d7;400). (c, d) Immunohistochemical staining shows that the lymphocytes were positive for CD20 and negative for CD3 (c: CD20 &#x000d7;400, d: CD3 &#x000d7;400).</p></caption><graphic xlink:href="DEO2-5-e414-g003" position="anchor" id="jats-graphic-5"/></fig><p>The patient received endoscopic biliary drainage (8.5Fr &#x000d7; 7cm plastic stent [Flexima; Boston Scientific]) followed by systemic chemotherapy (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone [R&#x02010;CHOP]). After six courses of R&#x02010;CHOP, positron emission tomography&#x02010;CT showed the disappearance of 18&#x02010;fluorodeoxyglucose uptake in the bile duct, and contrast&#x02010;enhanced CT and endoscopic retrograde cholangiography showed improvement in the bile duct stricture, (Figure <xref rid="deo2414-supitem-0002" ref-type="supplementary-material">S2</xref>). Follow&#x02010;up has been performed with contrast&#x02010;enhanced CT every 3&#x02013;6 months.</p></sec></sec><sec id="deo2414-sec-0030"><title>DISCUSSION</title><p>Herein, we describe a rare case of primary biliary DLBCL, diagnosed pathologically after a detailed endoscopic examination. The EUS and IDUS findings in this case accurately reflect the characteristics of PBML as a non&#x02010;epithelial lesion. To our knowledge, this is the first report showing the details of EUS and IDUS findings in a patient with primary biliary DLBCL.</p><p>The gastrointestinal tract is the most common primary site of extranodal lymphoma,<xref rid="deo2414-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref> but malignant lymphoma arising from the extrahepatic bile duct is extremely rare. In addition to the 32 cases summarized by Kato et&#x000a0;al.<xref rid="deo2414-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> from 1982 to 2015, 11 cases were reported by 2023, and a total of 43 cases of PBML were reported. Patient characteristics are presented in Table&#x000a0;<xref rid="deo2414-tbl-0001" ref-type="table">1</xref>. Twenty&#x02010;seven patients were male and 16 were female, with a median age of 59 years (range 4&#x02013;86 years). The most frequent type of lymphoma was DLBCL (34.9 %). Notably, 88.4 % (38 cases) of all patients were diagnosed by postoperative pathology, and only four were diagnosed by endoscopic bile duct biopsy.<xref rid="deo2414-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>, <xref rid="deo2414-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>, <xref rid="deo2414-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>, <xref rid="deo2414-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref>
</p><table-wrap position="float" id="deo2414-tbl-0001" content-type="TABLE"><label>TABLE 1</label><caption><p>Characteristics of previously reported patients with primary biliary malignant lymphoma.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="char" char="(" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">n</italic> = 43</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age, median (range)</td><td align="left" rowspan="1" colspan="1">59 (4&#x02013;86)</td></tr><tr><td align="left" rowspan="1" colspan="1">Male:female sex</td><td align="left" rowspan="1" colspan="1">27:16</td></tr><tr><td align="left" rowspan="1" colspan="1">Type of lymphoma</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">DLBCL</td><td align="left" rowspan="1" colspan="1">15 (34.9%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">MALT lymphoma</td><td align="left" rowspan="1" colspan="1">8 (18.6%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Follicular lymphoma</td><td align="left" rowspan="1" colspan="1">5 (11.6%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Other/unknown</td><td align="left" rowspan="1" colspan="1">15 (34.9%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Diagnosis</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Postoperative pathology</td><td align="left" rowspan="1" colspan="1">38 (88.4%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Endoscopic biopsy<xref rid="deo2414-tbl1-note-0001" ref-type="table-fn">
<sup>&#x02020;</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">4 (9.3%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Percutaneous liver biopsy<xref rid="deo2414-tbl1-note-0002" ref-type="table-fn">
<sup>&#x02021;</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">1 (2.3%)</td></tr></tbody></table><table-wrap-foot><fn id="deo2414-tbl1-note-0001"><label>
<sup>&#x02020;</sup>
</label><p>Biopsies were performed under fluoroscopy in 3 patients, and under cholangioscopy in 1 patient.</p></fn><fn id="deo2414-tbl1-note-0002"><label>
<sup>&#x02021;</sup>
</label><p>Liver biopsy of the site of liver infiltration was performed.</p></fn><fn id="deo2414-tbl1-note-0003"><p>Abbreviations: DLBCL, diffuse large B&#x02010;cell lymphoma; MALT, mucosa&#x02010;associated lymphoid tissue</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><p>Malignant gastrointestinal lymphoma, which is classified as a non&#x02010;epithelial lesion, arises from the submucosal tissue and shows a submucosal tumor&#x02010;like appearance, especially in the early phase.<xref rid="deo2414-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref> It is considered that PBML shows similar features as gastrointestinal lymphoma. The characteristic of cholangiography in PBML is smooth bile duct stricture, which reflects a submucosal tumor&#x02010;like feature, but it is difficult to distinguish it from other diseases such as cholangiocarcinoma by findings of cholangiography alone. Therefore, it is important to combine with the other modalities such as EUS and IDUS. In the present case, EUS and IDUS findings showed irregular thickening of the inner hypoechoic layer of the bile duct without the disappearance of the innermost thin hyperechoic layer. On ultrasonography findings, the innermost hyperechoic layer reflects the mucosa of the bile duct, and the second hypoechoic layer reflects the fibromuscular layer or deeper.<xref rid="deo2414-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> Thus, we consider the EUS and IDUS findings in this case to accurately reflect the characteristics of PBML as a non&#x02010;epithelial lesion. Actually, the previous report describing pathological findings of PBML<xref rid="deo2414-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> shows the growth of tumor cells under normal biliary epithelium. The thin hyperechoic layer in the findings of EUS and IDUS represents the normal biliary epithelium, while the irregular thickened hypoechoic layer represents a subepithelial tumor.</p><p>Differential diagnoses for PBML include cholangiocarcinoma, immunoglobulin G4&#x02010;related sclerosing cholangitis (IgG4&#x02010;SC), and primary sclerosing cholangitis (PSC). Cholangiocarcinoma arises from the mucosal epithelium and invades horizontally and vertically; therefore, EUS and IDUS findings show irregular bile duct wall thickening with loss of the three&#x02010;layered structure (high&#x02010;low&#x02010;high echoic layers).<xref rid="deo2414-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref> IgG4&#x02010;SC manifests with the thickening of the second hypoechoic layer without the disappearance of the three&#x02010;layered structure, similar to PBML.<xref rid="deo2414-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> However, the thickening in IgG4&#x02010;SC is uniform and has an entire circumference, whereas that in PBML is irregular and unilateral. PSC is characterized by an irregular bile duct lumen and diverticular&#x02010;like protrusion due to severe inflammation of the bile duct mucosa, whereas PBML features a smooth bile duct lumen.<xref rid="deo2414-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> When EUS and IDUS findings suggest a non&#x02010;epithelial tumor, for example, PBML, repeated biopsies from the same site, the so&#x02010;called boring biopsy, may be useful for obtaining submucosal tissue for diagnosis. In this case, we simply performed biopsies aiming at the same level of bile duct under fluoroscopy using a large cup of biopsy forceps to make an effort to obtain submucosal bile duct tissue, therefore it may not have been possible to perform boring biopsies accurately. We consider that it is better to perform the biopsies under cholangioscopy, if possible. As for the number of biopsies, in the previously reported case,<xref rid="deo2414-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> the first and second bile duct biopsies (each four times) did not lead to diagnosis, and the third biopsies (six times) were conclusive. Although it is difficult to determine the adequate number of biopsies, we consider that at least 4&#x02013;5 times biopsies with large cup biopsy forceps may be necessary.</p><p>Among the previous four patients diagnosed by endoscopic biopsy, one patient received radiotherapy and three patients received chemotherapy. Malignant lymphoma can be cured by non&#x02010;surgical treatments, such as chemotherapy, radiotherapy, and chemoradiotherapy; in contrast, cholangiocarcinoma can be cured only by surgery. Therefore, the diagnosis of PBML based on endoscopic and biopsy findings is important to avoid unnecessary surgical treatment.</p><p>In conclusion, we described a case of primary biliary DLBCL in which endoscopic findings and repeated biopsies were useful for making the diagnosis. Further investigation is needed to establish the endoscopic findings of rare types of biliary lesions such as malignant lymphoma.</p></sec><sec sec-type="COI-statement" id="deo2414-sec-0050"><title>CONFLICT OF INTEREST STATEMENT</title><p>None.</p></sec><sec id="deo2414-sec-0060"><title>ETHICS STATEMENT</title><p>Approval of the research protocol by an Institutional Reviewer Board is not applicable.</p></sec><sec id="deo2414-sec-0070"><title>PATIENT CONSENT STATEMENT</title><p>Informed consent was obtained from the patient for publication of this case report.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="deo2414-supitem-0001" position="float" content-type="local-data"><caption><p>Figure S1: Each enhance level image of contrast&#x02010;enhanced CT</p></caption><media xlink:href="DEO2-5-e414-s002.docx"/></supplementary-material><supplementary-material id="deo2414-supitem-0002" position="float" content-type="local-data"><caption><p>Figure S2: Findings of ERC, contrast&#x02010;enhanced CT, and positron emission&#x02010;CT before and after treatment</p></caption><media xlink:href="DEO2-5-e414-s003.docx"/></supplementary-material><supplementary-material id="deo2414-supitem-0003" position="float" content-type="local-data"><caption><p>Video: Video of ERC with repeated bile duct biopsies</p></caption><media xlink:href="DEO2-5-e414-s001.mp4" mimetype="video" mime-subtype="mp4"/></supplementary-material></sec></body><back><ack id="deo2414-sec-0040"><title>ACKNOWLEDGMENTS</title><p>The authors wish to thank Dr. Tomoyuki Yamakawa (Department of Hematology, Obihiro Kosei Hospital) for providing the chemotherapeutic course.</p></ack><ref-list id="deo2414-bibl-0001"><title>REFERENCES</title><ref id="deo2414-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="deo2414-cit-0001">
<string-name>
<surname>&#x000d6;demi&#x0015f;</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Parlak</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Ba&#x0015f;ar</surname>
<given-names>&#x000d6;</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Biliary tract obstruction secondary to malignant lymphoma: Experience at a referral center</article-title>. <source>Dig Dis Sci</source>
<year>2007</year>; <volume>52</volume>: <fpage>2323</fpage>&#x02013;<lpage>2332</lpage>.<pub-id pub-id-type="pmid">17406815</pub-id>
</mixed-citation></ref><ref id="deo2414-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="deo2414-cit-0002">
<string-name>
<surname>Kato</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Tsujie</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wakasa</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Primary diffuse large B cell lymphoma of the common bile duct causing obstructive jaundice</article-title>. <source>Int Canc Conf J</source>
<year>2016</year>; <volume>5</volume>: <fpage>107</fpage>&#x02013;<lpage>112</lpage>.</mixed-citation></ref><ref id="deo2414-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="deo2414-cit-0003">
<string-name>
<surname>Nakamura</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Matsumoto</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Iida</surname>
<given-names>M</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Primary gastrointestinal lymphoma in Japan: A clinicopathologic analysis of 455 patients with special reference to its time trends</article-title>. <source>Cancer</source>
<year>2003</year>; <volume>97</volume>: <fpage>2462</fpage>&#x02013;<lpage>2473</lpage>.<pub-id pub-id-type="pmid">12733145</pub-id>
</mixed-citation></ref><ref id="deo2414-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="deo2414-cit-0004">
<string-name>
<surname>Hwang</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Song</surname>
<given-names>TJ</given-names>
</string-name>, <string-name>
<surname>So</surname>
<given-names>S</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Primary biliary mucosa&#x02010;associated lymphoid tissue lymphoma mimicking hilar cholangiocarcinoma</article-title>. <source>Korean J Gastroenterol</source>
<year>2016</year>; <volume>68</volume>: <fpage>114</fpage>.<pub-id pub-id-type="pmid">27554220</pub-id>
</mixed-citation></ref><ref id="deo2414-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="deo2414-cit-0005">
<string-name>
<surname>Inoue</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Takeda</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Okita</surname>
<given-names>M</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>A case of mucosa&#x02010;associated lymphoid tissue lymphoma of the bile duct diagnosed using intraductal ultrasonography and transpapillary investigation of the bile duct</article-title>. <source>J Jpn Soc Gastroenterol</source>
<year>2020</year>; <volume>117</volume>: <fpage>345</fpage>&#x02013;<lpage>353</lpage>. Japanese.</mixed-citation></ref><ref id="deo2414-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="deo2414-cit-0006">
<string-name>
<surname>Sakashita</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Matsuda</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Omizo</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Bile duct MALT lymphoma diagnosed with direct cholangioscopy: A case report</article-title>. <source>Clin J Gastroenterol</source>
<year>2022</year>; <volume>15</volume>: <fpage>1145</fpage>&#x02013;<lpage>1150</lpage>
<pub-id pub-id-type="pmid">36053483</pub-id>
</mixed-citation></ref><ref id="deo2414-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="deo2414-cit-0007">
<string-name>
<surname>Imai</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Sekine</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Aoyama</surname>
<given-names>K</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>A case of primary bile duct diffuse large B&#x02010;cell lymphoma diagnosed by repeated endoscopic ultrasound&#x02010;guided fine&#x02010;needle aspiration and endoscopic retrograde cholangiopancreatography</article-title>. <source>Intern Med</source>
<year>2023</year>; <volume>63</volume>: 1776&#x02013;23.</mixed-citation></ref><ref id="deo2414-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="deo2414-cit-0008">
<string-name>
<surname>Yuge</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Oka</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Tanaka</surname>
<given-names>S</given-names>
</string-name>. <article-title>Endoscopic diagnosis of gastrointestinal malignant lymphoma</article-title>. <source>Gastroenterol Endosc</source>
<year>2023</year>; <volume>65</volume>: <fpage>107</fpage>&#x02013;<lpage>116</lpage>. Japanese.</mixed-citation></ref><ref id="deo2414-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="deo2414-cit-0009">
<string-name>
<surname>Harima</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Aibe</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Noguchi</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>A study of choledocheal diseases by endoscopic ultrasonography (EUS)</article-title>. <source>Gastroenterol Endosc</source>
<year>1989</year>; <volume>31</volume>: <fpage>837</fpage>&#x02013;<lpage>847</lpage>. Japanese.</mixed-citation></ref><ref id="deo2414-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="deo2414-cit-0010">
<string-name>
<surname>Naitoh</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Nakazawa</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hayashi</surname>
<given-names>K</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Comparison of intraductal ultrasonography findings between primary sclerosing cholangitis and IgG4&#x02010;related sclerosing cholangitis</article-title>. <source>J Gastroenterol Hepatol</source>
<year>2015</year>; <volume>30</volume>: <fpage>1104</fpage>&#x02013;<lpage>1109</lpage>.<pub-id pub-id-type="pmid">25594435</pub-id>
</mixed-citation></ref></ref-list></back></article>